Continental Investors Services, Inc. Genetic Technologies LTD Transaction History

Continental Investors Services, Inc.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 22, 2022	BUY	$0.0 - $6.4 $0 - $204,800	32,000 New	32,000 $47,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Continental Investors Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Continental Investors Services, Inc. with notifications on news.